After Hours Summary: CVGI -18%, TLYS -13% following earnings/guidance, QCOM -4.5% / AVGO -1.1% after exec order issued blocking mergerAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: VNET +5.1% (light volume), AMPH +2%, COUP +1.9%, TTEC +1.9% (thinly traded), KRO +1.5%, X +0.5% (provides 2018 guidance with EBITDA of ~$1.7 bln and reaffirms Q1 EBITDA guidance of ~$250 mln)
Companies trading higher in after hours in reaction to news: PTI +40.1% (announces that the FDA has granted Breakthrough Therapy Designation for PTI-428, the Co's cystic fibrosis transmembrane conductance regulator amplifier), ALT +16.1% (Altimmune announces data from a pre-clinical study comparing SparVax-L and BioThrax against anthrax infection; data from the study showed a 67% survival rate in animals challenged with a lethal dose of anthrax after a single dose of SparVax-L), WTI +5.8% (entered into joint exploration and development agreements with a group of investors with initial capital commitment of $230.5 million), AMRN +3.5% (Vascepa showed reductions in potentially atherogenic lipids and inflammatory markers), DRYS +2.4% (modestly higher after releasing investor presentation), INTC +1.3% (following QCOM/AVGO news; also mentioned positively on MadMoney), MU +1.1% (extending today's move higher in after hours -- tgt being raised to $66 from $55 at Mizuho as checks from Asia trip point to continued DRAM/NAND demand and price momentum into the JunQ)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: CVGI -17.7%, TLYS -13.2%, LBRT -13.1%, NCMI -11.2%, FENG -10.8% (ticking lower), KURA -7.5%, SFIX -5.1%
Companies trading lower in after hours in reaction to news: ADXS -22.6% (announces clinical hold in Axalimogene Filolisbac Phase 1/2 combination study with AstraZeneca's IMFINZI; reprots Q1 results), BL -5.2% (commences an underwritten public offering of 8 mln shares of its common stock by selling shareholders; BlackLine will not receive any proceeds from this offering), QCOM -4.5% / AVGO -1.8% (Qualcomm acquisition by Broadcom blocked by President Trump), MYGN -4.7% (recently received a Subpoena from the Department of Health and Human Services, Office of Inspector General, in connection with an investigation into possible false or otherwise improper claims submitted for payment under Medicare and Medicaid), EDIT -3.5% (files mixed securities shelf offering and files for $150 mln common stock shelf offering), FINL -3.3% (light volume; initiated with Underperform at Credit Suisse), AQUA -2.7% (acquires Pacific Ozone Technology to expand industrial disinfection treatment solutions; launches secondary public offering of 17,500,000 shares of common stock by certain stockholders), MC -2% (commences offering of 5,000,000 shares of Class A common stock), SABR -1.4% (announces the secondary public offering of 15,000,000 shares of common stock by existing shareholders), AWI -1.4% (attributed to block trade pricing), JCP -1.2% (initiated with Underperform at Credit Suisse)